http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MX-2015016123-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d32a49211015b18ecef5a3a5195bf06e |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7053 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7069 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-485 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0014 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F13-0256 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4748 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-485 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-04 |
| filingDate | 2014-06-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1229204194dce1238e61f431002158ec http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fe05069eaada20b719f538f68ef9daa7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3d31788f2842ecb31bfb9d3cefd0f185 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_71277b4f8ab114a7a0dd020ac6d409d5 |
| publicationDate | 2016-07-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | MX-2015016123-A |
| titleOfInvention | TRANSDERMAL RELEASE SYSTEM. |
| abstract | The invention relates to a transdermal therapeutic system for transdermal administration of buprenorphine, comprising a self-adhesive layer structure containing buprenorphine comprising A) a buprenorphine impermeable backing layer, and B) a pressure sensitive adhesive layer containing buprenorphine on said buprenorphine impermeable backing layer, the adhesive layer comprising a) at least one pressure sensitive polymer-based adhesive, b) an analgesically effective amount of buprenorphine base or a pharmaceutically acceptable salt thereof, c) a substance which increases the viscosity in an amount of about 0.1% to about 8% of said pressure sensitive adhesive layer containing buprenorphine, and d) a carboxylic acid selected from the group consisting of oleic acid, linoleic acid, linolenic acid, acid levulin and mixtures thereof, in an amount sufficient for said amount ef Buprenorphine-activated agent is solubilized therein to form a mixture including said substance that increases viscosity, and where the mixture containing carboxylic acid-, buprenorphine- and substance that increases viscosity forms dispersed deposits in said pressure sensitive adhesive, and where said pressure sensitive adhesive layer containing buprenorphine is the layer in contact with the skin. |
| priorityDate | 2013-06-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 35.